Therapeutic potential of CCR4 antagonists

New Drugs and Targets for Asthma and COPD

Volumn 39, Issue , 2010, Pages 161-165

  Hall, David ^a   Ford, Alison ^a   Hodgson, Simon ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880576137     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000320815     Document Type: Chapter

References (42)

1. Power CA,Wells TNC, (GlaxoSmithKline plc). Use of a chemokine receptor able to blind to MCP-1, MIP-1alpha and/or RANTES. EP 0805859 B1. Nov 12, 1997.
2. Power CA, Meyer A, Nemeth K et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995, 270(33): 19495-500.
3. Hoogewerf AJ, Black D, Proudfoot AEI, Wells TNC, Power CA. Molecular cloning of murine CC CKR-4 and high affinity binding of chemokines to murine and human CC CKR-4. Biochem Biophys Res Commun 1996, 218(1): 337-43.
4. Imai T, Yoshida T, Baba M, Nishimura M, Kakizishi M, Yoshie O. Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996, 271(35): 21514-21.
5. Imai T, Baba M, Nishimura M, Kakizishi M, Takagi S, Osamu Y. The T celldirected CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997, 272(23): 15036-42.
6. Imai T, Chantry D, Raport CJ et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998, 273(3): 1764-8.
7. Wang Y, Zhang Y, Yang X et al. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4). Life Sci 2006, 78(6): 614-21.
8. Han, W, lou Y, Tang J et al. Molecular cloning and characterisation of chemokinelike factor 1 (CKLF1) a novel human cytokine with a unique structure and potential chemotactic activity. Biochem J 2001, 357(Pt. 1): 127-35.
9. Bonecchi R, Bianchi G, Panina-Bourdignon P et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998, 187(1): 129-34.
10. Iellem A, Mariani M, Lang R et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+ CD25+ regulatory T cells. J Exp Med 2001, 194(6): 847-53.
11. Campbell JJ, HaraldsenG, Pan J et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999, 400(6746): 776-80.
12. Clemetson KJ, Clemetson JM, Proudfoot AEI, Power CA, Baggiolini M, Wells TNC. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 2000, 96(13): 4046-54.
13. Juremalm M, Olsson N, Nilsson G. Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 2002, 297(13): 480-5.
14. Inngjerdingen M, Damaj B, Maghazachi A. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001, 97(2): 367-75.
15. Katschke KJ, Rottman JB, Ruth JH et al. Differential expression of chemokine receptors on peripheral blood, synovial fluid and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheumatism 2001, 44(5): 1022-32.
16. Imai T, Nagira M, Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999, 11(1): 81-8.
17. Larche M, Robinson D, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003, 111(3): 450-63.
18. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006, 97(11): 1139-46.
19. Baxter A, Johnson T, Stocks M, Roberts B, Kindon N (AstraZeneca AB). N-Pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases. WO 2003059893. Jul 24, 2003.
20. Habashita H, Kokubo M, Shibayama S, Tada H, Sagawa K (Ono Pharmaceutical Co., Ltd.) Ccr4 antagonist and medical use thereof. US 20060004010. January 5, 2006.
21. Kawano N, Kontani T, Masuda N et al. Synthesis and biological evaluation of 2,4-diaminoquinazoline derivatives and related compounds as novel CC chemokine receptor 4 (CCR4) antagonists. 234th ACS Natl Meet (August 19-23, Boston) 2007, Abst MEDI 376.
22. Purandare A, Wan H, Somerville J et al. Core exploration in optimization of chemokine receptor CCR4 antagonists. Bioorg Med Chem Lett 2007, 17(3): 679-82.
23. Chvatchko Y, Hoogewerf AJ, Meyer A et al. A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med 2000, 191(10): 1755-63.
24. Nouri-Aria KT, Wilson D, Francis JN et al. CCR4 in human allergen-induced late responses in the skin and lung. Eur J Immunol 2002, 32(7): 1933-8.
25. Panina-Boudignon P, Papi A, Mariani M et al. The CC-chemokine receptors CCR4 and CCR8 identify airway T cells of allergen challenged atopic asthmatics. J Clin Invest 2001, 107(11): 1357-64.
26. Jahnz-Rozyk K, Targowski T, paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy 2005, 60(5): 685-8.
27. Lezcano-Meza D, Negrete-Garcia MC, Dante-Escobedo M, Teran LM. The monocyte-derived chemokine is released in the bronchoalveolar lavage fluid of steady-state asthmatics. Allergy 2003, 58(11): 1125-30.
28. Pilette C, Francis JN, Till SJ, Durham SR. CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge. Eur Respir J 2004, 23(6): 876-84.
29. D'Ambrosio D, Albanesi C, Lang R, Girolomoni G, Sinigaglia F, Laudana C. Quantitative differences in chemokine receptor engagement generate diversity in integrin-depedent lymphocyte adhesion. J Immunol 2002, 169(5): 2303-12.
30. Katou F, Ohtani H, Nakayama T et al. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. Am J Pathol 2001, 158(4): 1263-70.
31. Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L. Differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002, 169(12): 6673-6.
32. Vissers JL, Hartgers FC, Lindhout E, Teunissen MBM, Figdor CG, Adema, GJ. Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo. J Leukocyte Biol 2001, 69(5): 785-93.
33. Hidi R, Riches V, Al-Ali M et al. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES. J Immunol 2000, 164(1): 412-8.
34. Andrews G, Jones C, Wreggett K. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol Pharmacol 2008, 73(3): 855-67.
35. Amgen gaining rights to CCR4 antibody in $520M Kyowa deal. Bioworld Today, March 7, 2008.
36. Schuh JM, Power CA, Proudfoot AE, Kunkel SL, Lukacs NW, Hogaboom CM. Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice. FASEB J 2002, 16(10): 1313-5.
37. Meyer EH, Wurbel EA, Staton TL et al. iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. J Immunol 2007, 179(7): 4661-71.
38. Gonzalo JA, Pan Y, Lloyd CM et al. Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol 1999, 163(1): 403-11.
39. Kawasaki S, Takizawa H, Yoneyama H et al. Intervention of thymus and activation-regulated chemokine attenuates the development of allergic airway inflammation and hyperresponsiveness in mice. J Immunol 2001, 166(3): 2055-62.
40. Conroy DM, Jopling LA, Lloyd CM et al. CCR4 blockade does not inhibit allergic airways inflammation. J Leuk Biol 2003, 74: 558-63.
41. Jopling LA, Sabroe I, Andrew DP et al. The identification, characterization, and distribution of guinea pig CCR4 and epitope mapping of a blocking antibody. J Biol Chem 2002; 277(9): 6864-73.
42. Hammad H et al. CCR4 Blockade inhibits allergic airway inflammation in a humanized SCID mouse model of asthma. 102nd Int Conf Am Thorac Soc (May 19-24, San Diego) 2006, Abst A583.